A Call to Action: ERS Leadership Engages European Commission to Elevate Respiratory Health on the Political Agenda on August 2, 2026 Posted by
Beyond the Brain: How Obesity-Linked Lipids May Drive Alzheimer’s Progression on August 2, 2026 Posted by
The Vanguard of Discovery: Meet the 2026 Lloyd J. Old STARs and the Future of Immunotherapy on August 2, 2026 Posted by
The Internal Architect of Chaos: Understanding and Overcoming Self-Sabotage in Bipolar Disorder on August 2, 2026 Posted by
The Gold Standard of Core Stability: Why the Two-Minute Plank is the Ultimate Fitness Benchmark After 55 on August 2, 2026 Posted by
A Call to Action: ERS Leadership Engages European Commission to Elevate Respiratory Health on the Political Agenda on August 2, 2026 Posted by
Beyond the Brain: How Obesity-Linked Lipids May Drive Alzheimer’s Progression on August 2, 2026 Posted by
The Vanguard of Discovery: Meet the 2026 Lloyd J. Old STARs and the Future of Immunotherapy on August 2, 2026 Posted by
Posted in Medical Innovations Scribe Therapeutics Breaks Gene Editing IPO Drought with $129 Million Offering on July 24, 2026
Posted in Medical Innovations Biotech Weekly Roundup: From ARPA-H Gene Therapy Blueprints to Strategic Market Realignment on July 11, 2026
Posted in Medical Innovations MeiraGTx Secures $400 Million Lifeline from Oberland Capital to Accelerate Gene Therapy Portfolio on July 7, 2026
Posted in Respiratory Health FDA Expands Landmark CRISPR Gene Therapy Access to Toddlers with Sickle Cell and Beta Thalassemia on July 2, 2026
Posted in Medical Innovations From Gene Therapy High-Flyer to Strategic Exit: The Transformation of Passage Bio on June 25, 2026
Posted in Digital Health Tools Health Policy Brief: From Youth Tobacco Trends to the Ethics of Gene Editing on June 24, 2026
Posted in Medical Innovations The Regulatory Pivot: Regenxbio’s Bold Bet on Duchenne Gene Therapy Amidst FDA Leadership Flux on June 24, 2026
Posted in Digital Health Tools A New Frontier in Gene Editing: Serapha Bio Emerges with $230 Million and a Strategic Reverse Merger on June 23, 2026
Posted in Medical Innovations Industry Update: Executive Departures, Gene Therapy Breakthroughs, and Regulatory Shifts on June 19, 2026
Posted in Digital Health Tools A Regulatory Reversal: UniQure’s Path to Approval for Huntington’s Gene Therapy Clears Key Hurdle on June 17, 2026
